pharma
Zentiva k.s
Zentiva k.s.
Zentiva is a pharma organization headquartered in Praha 10, CZ. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sou
Praha 10, CZ HQ
1488 Founded
3,631 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Praha 10, CZ
- Founded
- 1488
- Employees
- 3,631
- Programs
- 1
- Drugs
- 3
- Patents
- 0
PERLA
Phase 2 · small molecule · Patients with moderate or severe oedema on a long-term treatment with amlodipine
PERLA for Patients with moderate or severe oedema on a long-term treatment with amlodipine is a Phase 2 program (small_molecule) at Zentiva k.s. with 1 ClinicalTrials.gov record(s).
Internal code PERLA
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Zentiva k.s.
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Patients with moderate or severe oedema on a long-term treatment with amlodipine
- Status
- active
- Trials
- 1